Brawn Biotech Ltd — Results, 26-05-2025: Result

Brawn Biotech Ltd. has announced a board meeting on 26th May 2025 to approve the financial results for the quarter and half-year ended March 31, 2025. The company reported total revenue of ₹489.35 lakh for the quarter and ₹1,53,805 lakh for the year. It recorded a net loss of ₹18,442 lakh for the year ended March 2025, reflecting continued operational challenges. Total assets stood at ₹2,048.80 Cr with equity at ₹336.23 Cr. The cash flow statement shows negative cash flow from operations and investing activities, indicating liquidity pressures. These results highlight ongoing financial stress, important for shareholders monitoring recovery prospects.